.After F2G's first attempt to obtain a new training class of antifungal to market was actually hinde...
.Moderna has pledged to cut R&D spending by $1.1 billion by 2027. The selection to retract the bu...
.Merely 4 months after Sanofi bet $80 million in ahead of time cash money on Fulcrum Therapeutics' l...
.Cancer company Oncternal Therapeutics is folding all its own medical trials and also laying off tea...
.Roche is keeping out hopes that its injectable weight problems possibility might eventually display...
.Novo Nordisk has elevated the top on a phase 1 trial of its own oral amylin and GLP-1 receptor co-a...
.Only a couple of quick weeks after winning an FDA Fast Track tag for its own investigational BTK de...
.Not long after a positive records drop for Eli Lilly's efsitora alfa, the Indianapolis-based provid...
.BridgeBio Pharma is actually lowering its gene treatment budget as well as drawing back coming from...
.GSK's attempt to build the 1st vaccine for genital herpes simplex infection (HSV) has actually fini...